Enliven Therapeutics, Inc (ELVN) Misses Q4 EPS by 2c

Enliven Therapeutics, Inc (NASDAQ: ELVN) reported Q4 EPS of ($0.48), $0.02 worse than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Enliven Therapeutics, Inc (ELVN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Phillips 66, Marathon Merger Talks Collapsed - Semafor